Cardiac MRI examinations typically involve the administration of a contrast agent. This allows for the evaluation of both early and late gadolinium enhancement phases. The early enhancement phase is utilized to identify conditions such as intracardiac thrombi or microvascular obstruction. Crucially, the late gadolinium enhancement phase requires contrast to detect changes in connective tissue within the myocardial muscle. Without contrast administration, it is not possible to accurately visualize and quantify myocardial fibrosis, including the localization and extent of non-viable cardiac tissue.